J Matti Vuorinen

Suggest Changes
Learn More
Meta‐analysis of all clinical data was conducted to compare toremifene 40–60 mg/day (TOR) with tamoxifen 20–40 mg/day (TAM) in postmenopausal women with estrogen receptor (ER) positive or ER unknown(More)
A new preservative-free fixed-dose combination of 0.0015% tafluprost, a prostaglandin F2α analog, and 0.5% timolol (TAF/TIM; Santen Oy, Tampere, Finland), a beta-adrenergic antagonist has recently(More)